Your browser doesn't support javascript.
loading
Rituximab-Containing Treatment Regimens May Imply a Long-Term Risk for Difficult-To-Treat Chronic Hepatitis E.
Schulz, Marten; Biedermann, Paula; Bock, Claus-Thomas; Hofmann, Jörg; Choi, Mira; Tacke, Frank; Hanitsch, Leif Gunnar; Mueller, Tobias.
Afiliação
  • Schulz M; Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, CVK, 13353 Berlin, Germany.
  • Biedermann P; Division of Viral Gastroenteritis, Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute, 13353 Berlin, Germany.
  • Bock CT; Division of Viral Gastroenteritis, Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute, 13353 Berlin, Germany.
  • Hofmann J; Institute of Virology, Charité Universitätsmedizin Berlin, Labor Berlin-Charité-Vivantes GmbH, 13353 Berlin, Germany.
  • Choi M; Department of Nephrology and Intensive Care Medicine, Charité Universitätsmedizin Berlin, 13353 Berlin, Germany.
  • Tacke F; Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, CVK, 13353 Berlin, Germany.
  • Hanitsch LG; Institute of Medical Immunology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
  • Mueller T; Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, CVK, 13353 Berlin, Germany.
Article em En | MEDLINE | ID: mdl-31947836

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Ribavirina / Rituximab / Hepatite Crônica Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Ribavirina / Rituximab / Hepatite Crônica Idioma: En Ano de publicação: 2020 Tipo de documento: Article